bpc-157 safety toxicity Peptide Therapy | Regenerative Medicine A-H. Gross presentation of injury

L., Filipcic, I., Rokotov, D

VEGF is elevated in BPC-157-treated tissue samples, signaling endothelial cells to proliferate and migrate toward the injury site

The typical escalation moves from 0.25 mg to 0.5 mg at week 5, then to 1 mg at week 9, followed by 1.7 mg at week 13, and finally reaching the full maintenance dose of 2.4 mg semaglutide with 2.4 mg cagrilintide at week 17

Published January 2008

These two properties together are exceedingly rare in neuroprotective compounds and open the door to practical administration protocols that do not require injections or intranasal delivery

BAC water is the standard for peptide reconstitution